TwoStep Therapeutics

Company OverviewTwoStep Therapeutics launched in 2024 by a group of visionary scientists from Stanford University including Dr. Caitlyn Miller Dr. Carolyn Bertozzi Dr. Jennifer Cochran and Dr. Ronald Levy. United by a common goal of creating more effective and safer cancer treatments

Company OverviewTwoStep Therapeutics launched in 2024 by a group of visionary scientists from Stanford University including Dr. Caitlyn Miller Dr. Carolyn Bertozzi Dr. Jennifer Cochran and Dr. Ronald Levy. United by a common goal of creating more effective and safer cancer treatments

Company OverviewTwoStep Therapeutics is a biotechnology company developing a pipeline built around a unique tumor-targeting polyspecific integrin-binding peptide (PIP) that can selectively bind several targets that are highly expressed on solid tumors. This multi-targeting feature ena

Company OverviewTwoStep Therapeutics is a biotechnology company developing a pipeline built around a unique tumor-targeting polyspecific integrin-binding peptide (PIP) that can selectively bind several targets that are highly expressed on solid tumors. This multi-targeting feature ena

Company OverviewTwoStep Therapeutics is a biotechnology company developing a pipeline built around a unique tumor-targeting polyspecific integrin-binding peptide (PIP) that can selectively bind several targets that are highly expressed on solid tumors. This multi-targeting feature ena

Company OverviewTwoStep Therapeutics is a biotechnology company developing a pipeline built around a unique tumor-targeting polyspecific integrin-binding peptide (PIP) that can selectively bind several targets that are highly expressed on solid tumors. This multi-targeting feature ena